Skip to main content
. 2019 Dec 11;10(4):631–640. doi: 10.1055/s-0039-3399487

Table 8. Postoperative complications in the study patients.

Variable Group A ( n = 250), n (%) Group B ( n = 154), n (%) Group C ( n = 41), n (%) Group D ( n = 11), n (%) Total ( n = 456), n (%) p -Value
Abbreviations: Hb, hemoglobin; ICU, intensive care unit; TLC, total leukocyte count.
Note: All values are number of patients (%).
Anemia (Hb < 8 g %) 5 (2) 5 (3.3) 4(9.8) 0 14 (3.1) 0.091
Thrombocytopenia (platelet count <100,000/mm 3 ) 5 (2) 15 (9.7) 13 (31.7) 6 (54.5) 39 (8.5) <0.001
Leukocytosis (TLC >1 1,000/mm 3 ) 149 (59.6) 98 (63.6) 23 (56.1) 7 (63.6) 277 (60.7) 0.781
Fever 58 (23.2) 66 (42.9) 21 (51.2) 10 (90.9) 155 (33.9) <0.001
Dyselectrolytemia 4(1.6) 10 (6.5) 5 (12.2) 1 (9.1) 20 (4.4) 0.003
Deranged renal function tests 1 (0.4) 1 (0.6) 0 0 2 (0.4) 1.000
Deranged liver function tests 0 0 1 (2.4) 0 1 (0.2) 0.114
Coagulopathy 2 (0.8) 3 (1.9) 6 (14.6) 2 (18.2) 13 (2.8) <0.001
Hemodynamic instability 3 (1.2) 1 (0.7) 1 (2.4) 0 5 (1.1) 0.544
Inotrope/vasopressor use 3 (1.2) 1 (0.7) 1 (2.4) 0 5 (1.1) 0.544
Transfusions 37 (14.8) 56 (36.4) 30 (73.2) 7 (63.6) 130 (28.5) <0.001
Multiorgan dysfunction 2 (0.8) 4(2.6) 1 (2.4) 0 7 (1.5) 0.378
Pulmonary infection 2 (0.8) 9 (5.8) 2 (4.9) 1 (9.1) 14 (3.1) 0.006
Sepsis 0 3 (1.95) 0 0 3 (0.66) 0.161
Urinary tract infection 1 (0.4) 1 (0.65) 0 0 2 (0.44) 1.000
Bloodstream infection 0 1 (0.65) 1 (2.44) 0 2 (0.44) 0.116
Wound infection 0 2 (1.3) 0 0 2 (0.44) 0.329
Reexploration for hematoma 6 (2.4) 4(2.6) 5 (12.2) 1 (9.09) 16 (3.51) 0.018
Hematoma 29 (11.6) 28 (18.18) 12 (29.27) 3 (27.27) 72 (15.79) 0.011
Tracheostomy 5 (2) 14 (9.09) 4 (9.76) 3 (27.27) 26 (5.7) <0.001
Prolonged ventilation 13 (5.2) 16 (10.4) 9(21.9) 2 (18.2) 40 (8.7) <0.001
Prolonged ICU stay 13 (5.2) 23 (14.9) 8 (19.5) 4 (36.4) 48 (10.5) <0.001
Prolonged hospital stay 112 (44.8) 95 (61.7) 32 (78) 9(81.8) 248 (54.4) 0.054
Poor neurological outcome 15 (6) 17 (11) 8 (19.5) 2 (18.2) 42 (9.2) 0.013